All In Biotech

Drug Trial Radar · NCT04363242

A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions

A Phase 1 Dose Escalation Trial of SYN125 Single Agent in Solid Tumors and in Combination With Fixed Dose SYN004 in Patients With Epithelial Cancers With EGFR Expressions.

Last checked: Nov 19, 2026Latest source record: Apr 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

22

Actual

Start

Apr 9, 2020

Primary completion

Jul 31, 2023

Study completion Sep 30, 2023

Sponsor

Lead sponsor
Synermore Biologics Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Synermore Biologics USA Limited
First posted
Apr 27, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1 Dose Escalation Trial of SYN125 Single Agent in the Treatment of Solid Tumors and in Combination With Fixed Dose SYN004 in Patients With Cancer of the Internal or External Lining of the Body.

Conditions

  • Epithelial Carcinoma
  • Solid Tumor

Interventions

  • SYN125Biological

    Administered by IV infusion

  • SYN004Biological

    Administered by IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Incidence of dose-limiting toxicities (DLTs)Time frame: Up to Day 28
  2. Part B: Incidence of dose-limiting toxicities (DLTs)Time frame: Up to Day 28

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • University of Kansas Cancer Center, Clinical Research Center, 4350 Shawnee Mission Parkway, MS 6004

    Fairway, Kansas

  • Henry Ford Health System, Henry Ford Hospital

    Brownstown, Michigan

  • Washington University School of Medicine

    St Louis, Missouri

  • University of Oklahoma, Peggy and Charles Stephenson Cancer Center, 800 Northeast 10th Street

    Oklahoma City, Oklahoma

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.